Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

670

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

December 31, 2006

Conditions
Kidney Cancer
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

recombinant interferon alfa

DRUG

fluorouracil

Trial Locations (12)

1000

Institut Jules Bordet, Brussels

1090

Academisch Ziekenhuis der Vrije Universiteit Brussel, Brussels

B-9300

Onze Lieve Vrouw Ziekenhuis Aalst, Aalst

B-2650

Universitair Ziekenhuis Antwerpen, Edegem

B-3000

U.Z. Gasthuisberg, Leuven

D-34125

Klinikum Kassel, Kassel

2300 CA

Leiden University Medical Center, Leiden

6202 AZ

Academisch Ziekenhuis Maastricht, Maastricht

6500 HB

Universitair Medisch Centrum St. Radboud - Nijmegen, Nijmegen

3000 CA

University Medical Center Rotterdam at Erasmus Medical Center, Rotterdam

3015 GJ

Erasmus MC - Sophia Children's Hospital, Rotterdam

833 10

National Cancer Institute - Bratislava, Bratislava

Sponsors
All Listed Sponsors
collaborator

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

lead

Medical Research Council

OTHER_GOV